Robert Edgardo Gerszten, M.D.
This page shows the publications co-authored by Robert Gerszten and Caroline Fox.
Urinary metabolites along with common and rare genetic variations are associated with incident chronic kidney disease. Kidney Int. 2017 06; 91(6):1426-1435.
Metabolite Profiles Predict Acute Kidney Injury and Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement. J Am Heart Assoc. 2016 Mar 15; 5(3):e002712.
2-Aminoadipic acid is a biomarker for diabetes risk. J Clin Invest. 2013 Oct; 123(10):4309-17.
A combined epidemiologic and metabolomic approach improves CKD prediction. J Am Soc Nephrol. 2013 Jul; 24(8):1330-8.
Metabolite profiles and the risk of developing diabetes. Nat Med. 2011 Apr; 17(4):448-53.
Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest. 2011 Apr; 121(4):1402-11.
Metabolite profiling identifies pathways associated with metabolic risk in humans. Circulation. 2012 May 08; 125(18):2222-31.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.